JNJ vs TEM · P/E 17, rev $49.37B vs rev $1.27B
Johnson & Johnson (JNJ) versus Tempus AI, Inc. Class A Common Stock (TEM) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Tempus AI, Inc. Class A Common Stock (TEM) is a health information services company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported TEM revenue for 2025-12-31 was $1.27B. Net income was -$245.0M. Revenue was up 83.4% from 2024-12-31 to 2025-12-31. TEM currently screens at market cap $8.76B.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. TEM currently screens at market cap $8.76B.
Not investment advice. Open the JNJ and TEM stock pages for the full models.
Not investment advice.